Industry News
Bacteria-SIDS connection identified
Monash University researchers have confirmed a link between bacterial infections and sudden infant death syndrome (SIDS). [ + ]
Concern over US plan to push up patent fees
A push for higher fees by the US Patent and Trademark Office (PTO) could spell trouble for small Australian biotechs and technology transfer companies. [ + ]
Varian to open HPLC production facility in Melbourne
Victoria has won a key investment in a $US200 million coup that sees a Silicon Valley production facility shift its base to Melbourne's east. [ + ]
Genesis begins trial for psoriasis treatment
Genesis Research and Development Corporation has commenced a Phase II clinical trial to test the efficacy of its PVAC treatment for psoriasis when administered in combination with Ultra Violet-B (UVB) light therapy. [ + ]
Grant money comes through for research facilities
After nine months of confusion and frustration, 15 major research facilities appear poised to enjoy the benefits of a five-year, $150 million Federal Government grant scheme. [ + ]
Xcell appoints regulatory team for US, Europe push
Perth-based devices group Xcell Diagnostics has gathered up a specialised regulatory affairs team to drive United States and European registration of its Funhaler product. [ + ]
IDT finalises trials facility purchase
Melbourne-based contract research and drug manufacturing company Institute of Drug Technology Australia (ASX: IDT) has finalised its purchase of a human clinical trials facility in Adelaide. [ + ]
US bio-IT outfit Tripos sets up shop in Aust
US bioinformatics software and discovery research company Tripos has reacted to the expanding Australian life science sector by setting up a direct presence here for the first time. [ + ]
Alzheimer's researcher wins Mayne Florey Medal
The Australian Institute of Political Science has presented Prof Colin Masters with the 2002 Mayne Florey Medal, recognising his world-leading research into the cause of Alzheimer's disease and other brain diseases of the elderly. [ + ]
Vision Systems buys UK biotech
Vision Systems ASX: VSL) has surprised the market by buying a UK biochemical manufacturer outright. [ + ]
GM sensitivities force caution on biotech R&D
Consumer sensitivities over genetically modified foods are forcing biotech researchers in Australia's sugar industry to walk a tightrope. [ + ]
Resarchers identify more tolerant wheat
Researchers at the University of Southern Queensland's Centre for Rural and Environmental Biotechnology are expanding major research and development projects for improved wheat crops in Australia and China.
[ + ]Monash appoints new synchro chair
Monash University has appointed Australia's first Professor of X-ray and Synchrotron Physics to build a research base for the National Synchrotron Project. [ + ]
Biotech software: from DIY to off the shelf
The task of creating specialised software tools to decipher the complexities of genes and proteins until recently has been a do-it-yourself project for the bio-research community. [ + ]
Biotech hits a big six in CRC applications
Biotechnology is making room for itself at the high table of Australia's scientific-industrial community, judging from the number of biotech-centric applications in the latest round of Cooperative Research Centre (CRC) funding. [ + ]